Chiglitazar clinical trials
Also written CS038 and Carfloglitazar.
How each study uses chiglitazar is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the chiglitazar studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 6
Chipscreen Biosciences, Ltd. (7) · Shengjing Hospital (1) · Second Xiangya Hospital of Central South University (1) · Beijing Friendship Hospital (1) · Yufan Wang (1) · Yanbing Li (1) · Shanghai Jiao Tong University School of Medicine (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses chiglitazar is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes MellitusRecruitingPhase 2Shanghai Jiao Tong University School of MedicineNCT07303803Written as Chiglitazar
- Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing PrediabetesNot yet recruitingNot applicableSecond Xiangya Hospital of Central South UniversityNCT07558525Written as Chiglitazar sodium
- The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related CirrhosisNot yet recruitingNot applicableBeijing Friendship HospitalNCT06773221Written as Chiglitazar 64mg
- A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)Not yet recruitingNot applicableYufan WangNCT06191328Written as Chiglitazar sodium
- Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 DiabetesNot yet recruitingNot applicableYanbing LiNCT06007014Written as Chiglitazar sodium
- Chiglitazar/Metformin in Non-obese Women With PCOSCompletedPhase 2/3Shengjing HospitalNCT06125587Written as Chiglitazar
- Chiglitazar Added to Metformin for Type 2 DiabetesCompletedPhase 3Chipscreen Biosciences, Ltd.NCT04807348Written as Chiglitazar 32mg
- Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal FunctionCompletedPhase 1Chipscreen Biosciences, Ltd.NCT05515458Written as Chiglitazar
- A Phase II Clinical Trial of Chiglitazar for NASHCompletedPhase 2Chipscreen Biosciences, Ltd.NCT05193916Written as chiglitazar sodium tablets
- Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedPhase 1Chipscreen Biosciences, Ltd.NCT05515445Written as Chiglitazar
- Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.CompletedPhase 1Chipscreen Biosciences, Ltd.NCT05681273Written as Chiglitazar
- Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes PatientsCompletedPhase 3Chipscreen Biosciences, Ltd.NCT02173457Written as Chiglitazar
- Study of Chiglitazar Compare With Placebo in Type 2 Diabetes PatientsCompletedPhase 3Chipscreen Biosciences, Ltd.NCT02121717Written as Chiglitazar
Codes
What other systems call chiglitazar · ClinicalTrials.gg INT005007
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C515629 | chiglitazar | One source NLM |
| Wikidata | Q76756105 | chiglitazar | One source Wikidata |
Also registered as carfloglitazar (UNII 8WE94VAO6U).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.